Form 8-K - Current report:
SEC Accession No. 0001558370-23-003170
Filing Date
2023-03-08
Accepted
2023-03-08 17:15:32
Documents
12
Period of Report
2023-03-02
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20230302x8k.htm   iXBRL 8-K 33855
  Complete submission text file 0001558370-23-003170.txt   143116

Data Files

Seq Description Document Type Size
2 EX-101.SCH cydy-20230302.xsd EX-101.SCH 3046
3 EX-101.LAB cydy-20230302_lab.xml EX-101.LAB 14189
4 EX-101.PRE cydy-20230302_pre.xml EX-101.PRE 9288
6 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20230302x8k_htm.xml XML 4263
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 23717057
SIC: 2834 Pharmaceutical Preparations